Navigation Links
The Global Pharmaceutical Fine Chemicals Market Outlook to 2015

NEW YORK, Oct. 18, 2011 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

The Global Pharmaceutical Fine Chemicals Market Outlook to 2015


This report provides a comprehensive overview of the global pharmaceutical fine chemicals market including the classification of PFCs, demand/supply dynamics, and the key deals and alliances in the PFC market. The report also analyzes the global PFC industry in terms of market dynamics (market size, drivers and resistors of growth), key merger and acquisitions and recent trends in the industry.

Features and benefits

* Evaluate the PFC market in terms of regulatory environment, demand/supply dynamics, market size and structure.

* Gain up-to-date information regarding the deals and alliances in the PFC industry and how they affect the major players in this market.

* Understand the basic PFC manufacturing processes and the raw materials used in their production.

* Understand how recent trends in the pharmaceutical market are responsible for shaping the trends in the PFC industry.

* Analyze the performance of the leading PFC players and gain an insight into their geographic reach, business segments, revenues, growth strategies.


Pharmaceutical fine chemicals are chemicals used in the manufacture of pharmaceutical products. The pharmaceutical industry being one of the largest clients of PFC industry, not only affects the sales dynamics of the PFC industry, but also catalyses certain trends in this industry.

The relative importance of India and China as manufacturing areas for fine chemicals and pharmaceutical APIs has increased over recent decades because of the cost benefits that these countries offer to the pharmaceutical companies.

The drive towards cost reduction in the pharmaceutical industry will continue to create pricing pressure on the fine chemicals industry. Moreover, the consolidation of the pharmaceutical sector will also reduce the number of potential customers for the PFC industry.

Your Key questions answered

* What is the market size and growth rate of the global pharmaceutical fine chemicals market?

* What are the main trends driving the growth of the global PFC market and how is the 'patent cliff' impacting PFC sales?

* Which are the key deals and alliances in the global PFC industry and how will they impact the stakeholders?

* Which are the leading players in the global PFC market and what are their growth strategies?

* What are the key technological developments in the global PFC market?

Table of Contents

About Business Insights 2

Disclaimer 2

Executive summary 9

Industry overview 9

Market overview 10

Recent trends in the pharmaceutical fine chemicals industry 11

Competitive landscape 11

Scope and methodology 13

Scope 13

Methodology 13

Chapter 1 Industry overview 15

Summary 15

Introduction 16

Classification of pharmaceutical fine chemicals (PFCs) 17

Basic intermediates 18

Key intermediates 19

Active pharmaceutical ingredients 19

Demand for pharmaceutical fine chemicals 20

Supply of pharmaceutical fine chemicals 21

Production of pharmaceutical fine chemicals 23

Raw materials used for the production of PFCs 23

Manufacturing procedures 24

Current regulatory environment for pharmaceutical intermediates 25

GMP requirements 25

ICH Q7A 25

US GMP – Federal Food Drug and Cosmetic Act 26


China GMP – GMP for pharmaceutical products 28

India GMP – Drugs and cosmetics rules Schedule M 29

Drug Price Competition and Patent Term Restoration Act ('Hatch-Waxman Act') 29


Key deals and alliances in the global pharmaceutical fine chemicals market 31

Chapter 2 Market overview 33

Summary 33

Introduction 34

Market dynamics 35

Global market size and structure 35

Regional distribution 37

Future outlook of the global PFC market 38

Drivers and resistors of PFC industry 41

Drivers of the PFC industry 42

Resistors of the PFC industry 44

Chapter 3 Recent trends in the pharmaceutical fine chemicals industry 46

Summary 46

Introduction 47

Increasing pricing pressure on PFC companies 48

Downturn in the innovative API market; upturn in the generic API market 48

Increasing PFC outsourcing is creating new growth opportunities 51

Recent innovations in the PFC manufacturing processes 52

Small molecule production technologies 52

Biotechnological manufacturing methods 55


Antibody-drug conjugates 57

Relocation to emerging and fast growing markets 57

Chapter 4 Competitive landscape 59

Summary 59

Introduction 60

Competitive landscape 60

Capability analysis 61

Albemarle Corporation 62

Company overview 62

Business segmentation 62

Financial performance 63

Growth strategy 63


Company overview 64

Business segmentation 64

Financial performance 66

Growth strategy 66

Boehringer Ingelheim 67

Company overview 67

Business segmentation 68

Financial performance 68

Growth strategy 69

Cambrex 69

Company overview 69

Business segmentation 69

Financial performance 70

Growth strategy 70

DSM 71

Company overview 71

Business segmentation 72

Financial performance 73

Growth strategy 74

Evonik 76

Company overview 76

Business segmentation 76

Financial performance 76

Growth strategy 78

Lonza 79

Company overview 79

Business segmentation 79

Financial performance 80

Growth strategy 81

Novasep 83

Company overview 83

Business segmentation 83

Financial performance 84

Growth strategy 84

Sigma-Aldrich 84

Company overview 84

Business segmentation 84

Financial performance 85

Growth strategy 85

Sumitomo Chemical 86

Company overview 86

Business segmentation 87

Financial performance 88

Growth strategy 88

Other major PFC companies 89

Archimica 89

Daiichi Fine Chemical 90

KemFine 90

Saltigo 91

Siegfried 92

Abbreviations 93

Table of figures

Figure 2: Classification of chemicals based on functionality and industrial applications 18

Figure 3: Supply chain of pharmaceutical fine chemicals 22

Figure 3: Relationship between the industries involved in the PFC market 34

Figure 4: Supply areas of pharmaceutical intermediates in 2009 38

Figure 5: Supply areas of Pharmaceutical intermediates in 2015 39

Figure 6: Drivers and resistors of pharmaceutical fine chemical industry 41

Figure 7: Pharmaceutical industry trends influencing the PFC industry 48

Figure 8: Effect of patent cliff on the API market 49

Figure 9: Capability analysis of the leading 10 PFC companies 61

Figure 10: Albemarle's fine chemicals division net sales 63

Figure 11: Cambrex's fine chemicals sales ($m), 2010 70

Figure 12: DSM's pharmaceutical division net sales ($m), 2010 74

Figure 13: Evonik's chemical division net sales ($m), 2010 78

Table of tables

Table 1: Differentiating characteristics of commodities, fine chemicals and specialty chemicals 17

Table 2: List of important basic pharmaceutical intermediates and their applications 19

Table 3: List of major natural sources used in the synthesis of APIs 23

Table 4: List of major petrochemical products used in the synthesis of APIs 23

Table 5: Global pharmaceutical market by country ($m), 2009 36

Table 6: Forecast sales performance of pharmaceutical fine chemicals, 2010–2015 39

Table 7: Patent expiries of key pharmaceutical compounds during 2010–2015 50

Table 8: Performance of leading PFC companies ($m), 2009 60

Table 9: BASF financial performance by segment ($m), 2009 66

Table 10: Boehringer Ingelheim financial performance by segment ($m), 2009 68

Table 11: DSM financial performance by segment ($m), 2009 73

Table 12: Evonik's Chemical division sales ($m), 2009 77

Table 13: Lonza financial performance ($m), 2009 80

To order this report:

: The Global Pharmaceutical Fine Chemicals Market Outlook to 2015

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
2. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
3. Directors Forum: PEPFAR and the Global AIDS Response
4. Alfacell Corporation to Present at UBS Global Life Sciences Conference
5. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
6. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
7. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
8. Hillary Clinton Pledges Bold Approach to Stopping HIV/AIDS & Global Poverty
9. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
10. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
11. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
Post Your Comments:
(Date:6/23/2016)... Research and Markets has announced the addition ... Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, Binder, ... Forecast to 2021" report to their offering. ... excipients market is projected to reach USD 8.1 Billion ... forecast period 2016 to 2021. The ...
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
(Date:6/23/2016)... , June 23, 2016 ... Oticon , industry leaders in advanced ... launch of Oticon Opn ™, the world,s first ... of possibilities for IoT devices.      (Photo: ... Oticon introduces a number of ,world firsts,: ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
(Date:6/24/2016)... ... ... crisis. Her son James, eight, was out of control. Prone to extreme mood shifts and ... him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife on ... say he was going to kill them. If we were driving on the freeway, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... 2016 , ... People across the U.S. are sharpening their pencils and honing ... contest in which patients and their families pay tribute to a genetic counselor by ... Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In ...
Breaking Medicine News(10 mins):